Afuco™ Anti-Human Angiostatin ADCC Therapeutic Antibody, ADCC Enhanced
Anti-Angiostatin ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. Anti-angiostatin receptor monoclonal antibody is a chimeric antibody, while maintaining its anti-angiostatin receptor activity, making it more suitable for in vivo applications. The monoclonal antibody has a natural tumor cell membrane surface antigen-binding activity and can inhibit tumor cell surface ATP synthesis, anti-tumor therapy has important significance.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-036CL |
| Pricing | Inquiry |
| Host | Chimeric (human/mouse) |
| Target | Angiostatin |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | 4°C or -20°C, avoid repeated freezing and thawing. |